A phase I-II study of high-dose recombinant human interleukin-2 in disseminated renal-cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I-II study of high-dose recombinant human interleukin-2 in disseminated renal-cell carcinoma

Published:1988 Issue:3 Volume:4 Page:207-209
ISSN:8756-0437
Container-title:Seminars in Surgical Oncology
language:en
Short-container-title:Semin. Surg. Oncol.

Author:

Javadpour N.,Lalehzarian M.

Publisher

Wiley

Subject

Oncology,Surgery

Reference7 articles.

1. : Management of renal cancer. In , (eds): “Principles of Cancer Treatment.” New York: McGraw-Hill Book Company, 1982, 571.

2. : Lymphokine research: A historical overview in lymphokine reports. (ed) Vol. 1: New York Academic Press, 1980, 1–5.

3. Human normal CTL clones: Generation and properties

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer;Journal of Oncology;2019-11-28

2. The Role of High Dose Interleukin-2 in the Era of Targeted Therapy;Journal of Urology;2017-09

3. Aldesleukin;Meyler's Side Effects of Drugs;2016

4. CYTOKINES AND CYTOKINE MODULATORS;Meyler's Side Effects of Drugs in Cancer and Immunology;2010

5. Aldesleukin;Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions;2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP